Being tested
Testosterone: protect nerve tissue in relapsing MS
relapsing MS · Sex hormones / hormonal
Trials are running now and no controlled trial has a readable result yet.
- Trials
- 2
- Running now
- 1
- Controlled phase 2/3 trials
- 1
- People in controlled trials
- 40
How the verdict was reached
No result yet
| Trial | Phase | Participants | Started | Result | Counted |
|---|---|---|---|---|---|
| TOTEM-RRMS | Phase 2 | 40 | 2019 | Still running | Will count when it reports |
| Testosterone, phase 2 | Phase1|phase2 | 10 | 2002 | Met its main goal | Not counted: not randomised |
Counted: 0. Will count later: 1. Not counted: 1.
Lab evidence
Lab studies in animals or cells. Results in animals often do not hold in people, and these studies never change the status of an idea.
Loading lab studies…
Loading reviews and guidelines…
History
- Oct 2026First listed as Being tested
Related hypotheses
- Testosterone undecanoate: protect nerve tissue in relapsing MS
- Testosterone: protect nerve tissue in MS (type not specified)
- Sex hormones / hormonal: repair myelin in relapsing MS
- Estriol: reduce relapses and new lesions in relapsing MS
- Somatropin: reduce relapses and new lesions in relapsing MS
- Testosterone undecanoate: reduce relapses and new lesions in relapsing MS
Assembled by software from public sources.